The worst-case scenario is that Amgen continues to erase any growth Procrit can manage, and the Cypher stent can't make up the difference.

FORBES: Magazine Article

Weldon launched the first drug-coated stent, Cypher, for angina, a kind of heart pain, and then had so much trouble competing with Abbott and other rivals that it eventually closed the division.

FORBES: Weldon's Legacy At J&J Goes Beyond Badly Made Baby Medicine

Investors are still waiting for news on Cypher, a drug-coated stent that many are hoping will make up for slowing drug sales.

FORBES: Magazine Article